These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38828373)

  • 61. Molecular epidemiology and outcome of carbapenem-resistant Enterobacterales in Saudi Arabia.
    Alraddadi BM; Heaphy ELG; Aljishi Y; Ahmed W; Eljaaly K; Al-Turkistani HH; Alshukairi AN; Qutub MO; Alodini K; Alosaimi R; Hassan W; Attalah D; Alswaiel R; Saeedi MF; Al-Hamzi MA; Hefni LK; Almaghrabi RS; Anani M; Althaqafi A
    BMC Infect Dis; 2022 Jun; 22(1):542. PubMed ID: 35698046
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Risk Factors for Carbapenem-Resistant
    Yuan Y; Wang J; Yao Z; Ma B; Li Y; Yan W; Wang S; Ma Q; Zhang J; Xu J; Li L; Wang Y; Fan E
    Infect Drug Resist; 2020; 13():207-215. PubMed ID: 32158236
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Colistin versus polymyxin B for the treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
    Vieceli T; Henrique LR; Rech TH; Zavascki AP
    J Infect Chemother; 2024 Jul; 30(7):621-625. PubMed ID: 38244722
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections.
    Li J; Ren J; Wang W; Wang G; Gu G; Wu X; Wang Y; Huang M; Li J
    Eur J Clin Microbiol Infect Dis; 2018 Apr; 37(4):679-689. PubMed ID: 29238932
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mortality impact of empirical antimicrobial therapy in ESBL- and AmpC-producing Enterobacteriaceae bacteremia in an Australian tertiary hospital.
    Lim CL; Spelman D
    Infect Dis Health; 2019 Aug; 24(3):124-133. PubMed ID: 30928569
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Epidemiology, resistant pathogens, and causes of early death in cases of bloodstream infection in patients with hematological malignancies from 2012-2019.
    Li M; Du M; Li H; Liu D; Liu Y
    Infect Med (Beijing); 2022 Mar; 1(1):23-30. PubMed ID: 38074981
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
    Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
    Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
    Ann Hematol; 2012 Jan; 91(1):115-21. PubMed ID: 21556875
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bloodstream Infections Caused by Carbapenem-Resistant
    Zhou C; Jin L; Wang Q; Wang X; Chen F; Gao Y; Zhao C; Chen H; Cao B; Wang H
    Infect Drug Resist; 2021; 14():731-742. PubMed ID: 33658810
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections.
    Huang SR; Liu MF; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2014 Jun; 47(3):187-96. PubMed ID: 23200553
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Characteristics of epidemiology and antimicrobial resistance of gram-negative bacterial bloodstream infections in children].
    Dong L; Zhang XY; Li CC; Li Z; Xia YQ
    Zhonghua Er Ke Za Zhi; 2017 Sep; 55(9):683-688. PubMed ID: 28881515
    [No Abstract]   [Full Text] [Related]  

  • 72. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
    Tumbarello M; Sanguinetti M; Montuori E; Trecarichi EM; Posteraro B; Fiori B; Citton R; D'Inzeo T; Fadda G; Cauda R; Spanu T
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1987-94. PubMed ID: 17387156
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical characteristics and risk factors for shock and death from E. coli bacteremia in pediatric hematological patients.
    Wang H; Liu J; Huang Z; Tao X; Li J; Hu Y; Dou Q; Zou M; Yan Q; Liu WE
    J Infect Dev Ctries; 2019 May; 13(5):365-373. PubMed ID: 32053505
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies.
    Satlin MJ; Cohen N; Ma KC; Gedrimaite Z; Soave R; Askin G; Chen L; Kreiswirth BN; Walsh TJ; Seo SK
    J Infect; 2016 Oct; 73(4):336-45. PubMed ID: 27404978
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical and Molecular Characteristics of Patients with Bloodstream Infections Caused by KPC and NDM Co-Producing Carbapenem-Resistant
    Li J; Wu W; Wu M; Zhou Z; Wang J; Qiu M; Xu L; Ren J; Wu X
    Infect Drug Resist; 2024; 17():1685-1697. PubMed ID: 38711471
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Combined prognostic value of serum lactic acid, procalcitonin and severity score for short-term prognosis of septic shock patients].
    Hao C; Hu Q; Zhu L; Xu H; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Mar; 33(3):281-285. PubMed ID: 33834968
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Shifting trends and age distribution of ESKAPEEc resistance in bloodstream infection, Southwest China, 2012-2017.
    Yang S; Xu H; Sun J; Sun S
    Antimicrob Resist Infect Control; 2019; 8():61. PubMed ID: 30976388
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bloodstream infections and antimicrobial resistance of responsible pathogens in Ukraine: results of a multicenter study (2013-2015).
    Salmanov AG; Voronenko YV; Vozianov SO; Shunko YY; Mamenko MY; Verner OM; Mykhalchuk VM; Vydyborets SV; Shkorbotun VO; Beketova HV; Okhotnikova OM; Goryainova NV; Oshlianska OA; Laksha O; Bielova O; Shuba VY; Osadcha TM
    Wiad Lek; 2019; 72(11 cz 1):2069-2075. PubMed ID: 31860848
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
    Chang YY; Chuang YC; Siu LK; Wu TL; Lin JC; Lu PL; Wang JT; Wang LS; Lin YT; Huang LJ; Fung CP
    J Microbiol Immunol Infect; 2015 Apr; 48(2):219-25. PubMed ID: 25074627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.